|Bid||1.5200 x 800|
|Ask||1.5700 x 3000|
|Day's Range||1.5000 - 1.5817|
|52 Week Range||1.3000 - 4.2400|
|Beta (5Y Monthly)||1.61|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 13, 2021 - May 17, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced financial and operational results for the fourth quarter and fiscal year 2020, which ended on December 31, 2020.
NEW YORK, NY / ACCESSWIRE / March 25, 2021 / SenesTech, Inc. (NASDAQ:SNES) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 25, 2021 at 5:00 PM Eastern Time.
Aptose Biosciences Inc (NASDAQ: APTO) shares are trading higher after the company reported fourth-quarter earnings results. Oppenheimer analyst Matthew Biegler also maintains Aptose with an Outperform and raises the price target from $8 to $9. Aptose is a biotechnology company. The company develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. SenesTech Inc (NASDAQ: SNES) shares are trading higher after the company announced the initiation of a collaboration with Liphatech to develop a non-liquid formulation of ContraPest. SenesTech is a biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. See also: Best Penny Stocks Under See more from BenzingaClick here for options trades from BenzingaWhat's Happening With LIVX Stock And EYES Stock Wednesday?Thinking About Buying Stock Or Options In Wells Fargo, Netflix, Microsoft Or Apple?© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.